EXELIXIS INC's ticker is EXEL and the CUSIP is 30161Q104. A total of 374 filers reported holding EXELIXIS INC in Q2 2022. The put-call ratio across all filers is 0.21 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $349,600 | +14.3% | 16,000 | 0.0% | 0.25% | +29.2% |
| Q2 2023 | $305,760 | -1.5% | 16,000 | 0.0% | 0.19% | -9.4% |
| Q1 2023 | $310,560 | +21.0% | 16,000 | 0.0% | 0.21% | +7.1% |
| Q4 2022 | $256,640 | +2.2% | 16,000 | 0.0% | 0.20% | +9.4% |
| Q3 2022 | $251,000 | -24.6% | 16,000 | 0.0% | 0.18% | -14.6% |
| Q2 2022 | $333,000 | -99.9% | 16,000 | 0.0% | 0.21% | +39.5% |
| Q1 2022 | $366,880,000 | +125543.8% | 16,000 | 0.0% | 0.15% | +34.5% |
| Q4 2021 | $292,000 | – | 16,000 | – | 0.11% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Meditor Group Ltd | 17,416,738 | $422,007,000 | 64.06% |
| Matrix Capital Management Company, LP | 15,117,460 | $366,296,000 | 11.71% |
| Rhenman & Partners Asset Management AB | 1,050,000 | $25,442,000 | 3.25% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 254,334 | $6,163,000 | 2.40% |
| BOGLE INVESTMENT MANAGEMENT L P /DE/ | 790,148 | $19,145,000 | 1.30% |
| Jupiter Investment Management Ltd | 4,182,760 | $101,348,000 | 1.06% |
| INSIGHT CAPITAL RESEARCH & MANAGEMENT INC | 50,818 | $1,231,000 | 0.70% |
| C M BIDWELL & ASSOCIATES LTD | 17,475 | $423,000 | 0.65% |
| QCM Cayman, Ltd. | 9,562 | $232,000 | 0.60% |
| Handelsinvest Investeringsforvaltning | 98,500 | $2,387,000 | 0.56% |